Affordable Access

deepdyve-link
Publisher Website

Long-Term Outcomes of Two Different Initial Dosing Regimens of Intravitreal Ranibizumab Used to Treat Myopic Choroidal Neovascularization.

Authors
  • Calvo-González, Cristina1
  • Reche-Frutos, Juan
  • Fernández-Vigo, José Ignacio
  • Sáenz-Francés, Federico
  • Fernández-Pérez, Cristina
  • García-Feijóo, Julian
  • 1 Department of Ophthalmology, Hospital Universitario Clínico San Carlos, and Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain. , (Spain)
Type
Published Article
Journal
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
Publication Date
Jan 01, 2017
Volume
238
Issue
4
Pages
196–204
Identifiers
DOI: 10.1159/000478030
PMID: 28881344
Source
Medline
Keywords
License
Unknown

Abstract

Both dosing regimens led to similar visual outcomes. For eyes given a single injection in the first quarter, retreatment was needed appreciably earlier.

Report this publication

Statistics

Seen <100 times